LTR Pharma (ASX:LTP) Other Current Liabilities: A$0.34 Mil (As of Dec. 2025)


ASX:LTP LTR Pharma Ltd ASX:LTP
15 GF Score
Price A$0.58
View Full Analysis

What is LTR Pharma Other Current Liabilities?

LTR Pharma ASX:LTP +6.48% 15 Other Current Liabilities is A$0.34 Mil as of Dec. 2025. GuruFocus rates ASX:LTP with a GF Score™ of 15/100.

LTR Pharma's other current liabilities for the quarter that ended in Dec. 2025 was A$0.34 Mil.

LTR Pharma's quarterly other current liabilities increased from Dec. 2024 (A$0.18 Mil) to Jun. 2025 (A$0.60 Mil) but then declined from Jun. 2025 (A$0.60 Mil) to Dec. 2025 (A$0.34 Mil).

LTR Pharma's annual other current liabilities increased from Jun. 2023 (A$0.01 Mil) to Jun. 2024 (A$0.19 Mil) and increased from Jun. 2024 (A$0.19 Mil) to Jun. 2025 (A$0.60 Mil).

LTR Pharma Other Current Liabilities Related Terms

LTR Pharma Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for LTR Pharma's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LTR Pharma Other Current Liabilities Chart

LTR Pharma Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Other Current Liabilities
0.10 0.01 0.01 0.19 0.60

LTR Pharma Semi-Annual Data
Jun21 Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Liabilities Get a 7-Day Free Trial 0.12 0.19 0.18 0.60 0.34
ASX:LTP
15GF Score
LTR Pharma Ltd ASX:LTP
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LTR Pharma Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of A$0.34 Mil mean?
LTR Pharma (ASX:LTP) has a Other Current Liabilities of A$0.34 Mil as of Dec. 2025. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on LTR Pharma.
Is LTR Pharma's Other Current Liabilities too high?
LTR Pharma's current Other Current Liabilities is A$0.34 Mil. Overall, LTR Pharma has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does LTR Pharma's Other Current Liabilities compare to VRTX and REGN?
LTR Pharma's Other Current Liabilities of A$0.34 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on LTR Pharma. LTR Pharma's current Other Current Liabilities is A$0.34 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LTR Pharma stock overvalued right now?
LTR Pharma (ASX:LTP) has a current Other Current Liabilities of A$0.34 Mil. The current Other Current Liabilities is A$0.34 Mil. LTR Pharma's overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For LTR Pharma (ASX:LTP), the current Other Current Liabilities is A$0.34 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LTR Pharma Business Description

Address 9A/204 Alice Street, Brisbane, QLD, AUS, 4000
LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on the market.
15GF Score

Get the complete analysis for ASX:LTP

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.58
Price